GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Neogen Corp (STU:NG2) » Definitions » Capital Expenditure

Neogen (STU:NG2) Capital Expenditure : €-105.01 Mil (TTM As of Feb. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Neogen Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Neogen's cash flow for capital expenditures for the three months ended in Feb. 2025 was €-31.6 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Feb. 2025 was €-105.01 Mil.

Neogen Capital Expenditure Historical Data

The historical data trend for Neogen's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neogen Capital Expenditure Chart

Neogen Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22.06 -21.98 -23.11 -60.50 -103.06

Neogen Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -29.78 -22.44 -34.86 -16.16 -31.55

Neogen Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Feb. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-105.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neogen Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Neogen Corp (STU:NG2) » Definitions » Capital Expenditure
Comparable Companies
OPK CDNA GRAL NEO MYGN CSTL FLGT PSNL STIM ATLN TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT
Traded in Other Exchanges
NEOG:USA NG2:Germany
Address
620 Lesher Place, Lansing, MI, USA, 48912
Website
https://www.neogen.com
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.

Neogen Headlines

No Headlines